¼¼°èÀÇ µ¿¹°¿ë »ê¼Ò ¿ä¹ý ½ÃÀå
Veterinary Oxygen Therapy
»óǰÄÚµå : 1777672
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 366 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,180,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,541,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ µ¿¹°¿ë »ê¼Ò ¿ä¹ý ½ÃÀåÀº 2030³â±îÁö 16¾ï ´Þ·¯¿¡ µµ´Þ

2024³â¿¡ 12¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ µ¿¹°¿ë »ê¼Ò ¿ä¹ý ½ÃÀåÀº 2030³â¿¡´Â 16¾ï ´Þ·¯¿¡ ´ÞÇϸç, ºÐ¼® ±â°£ÀÎ 2024-2030³âÀÇ CAGRÀº 5.7%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ µ¿¹°¿ë »ê¼Ò¹ß»ý±â´Â CAGR 4.5%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 9¾ï 7,160¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¾×¼¼¼­¸® ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ Áß CAGR 7.5%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 3¾ï 2,110¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 8.7%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ µ¿¹°¿ë »ê¼Ò ¿ä¹ý ½ÃÀåÀº 2024³â¿¡´Â 3¾ï 2,110¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2024-2030³âÀÇ ºÐ¼® ±â°£¿¡ CAGR 8.7%·Î ÃßÀÌÇϸç, 2030³â¿¡´Â ¿¹Ãø ½ÃÀå ±Ô¸ð 3¾ï 2,740¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 2.8%¿Í 5.5%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 3.7%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°è µ¿¹°¿ë »ê¼Ò¿ä¹ý ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ Á¤¸®

µ¿¹°¿ë »ê¼Ò ¿ä¹ýÀÌ µ¿¹° ÇコÄɾ¼­ Á¡Á¡ ´õ Áß¿äÇØÁö´Â ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

µ¿¹°¿ë »ê¼Ò ¿ä¹ýÀº Àú»ê¼ÒÁõ, È£Èí°ï¶õ, ¼ö¼ú ÈÄ ÇÕº´ÁõÀ¸·Î °íÅë¹Þ´Â µ¿¹°¿¡°Ô »ý¸íÀ» ±¸Çϴ ȣÈí Áö¿øÀ» Á¦°øÇÔÀ¸·Î½á ÁßȯÀÚ Ä¡·á ¹× ÀÀ±ÞÀÇ·á¿¡ ÇʼöÀûÀÎ ¿ä¼Ò·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù. ¼öÀÇÇÐÀÌ ¹ßÀüÇÔ¿¡ µû¶ó º¸Á¶»ê¼ÒÀÇ Çʿ伺Àº ±âÁ¸ÀÇ ÁßȯÀڽǻӸ¸ ¾Æ´Ï¶ó ¼ö¼ú Àü/ÈÄ È¸º¹, ¿Ü»ó Ä¡·á, ¹Ý·Áµ¿¹° Æó·Å, ±â°üÇãÅ», ¿ïÇ÷¼º½ÉºÎÀü µî ¸¸¼º È£Èí±â ÁúȯÀÇ °ü¸®±îÁö È®´ëµÇ°í ÀÖ½À´Ï´Ù. ÀÛÀº µ¿¹°, ƯÈ÷ ºÒµ¶À̳ª ÆÛ±×¿Í °°Àº ´ÜµÎÁ¾Àº ƯÈ÷ È£Èí°ï¶õ¿¡ ºüÁö±â ½¬¿ì¸ç, ±Þ¼º ¹× ¸¸¼º Ä¡·á¿¡¼­ »ê¼Ò ¿ä¹ýÀÌ ÇÊ¿äÇÕ´Ï´Ù. ¶ÇÇÑ ¹Ì¼÷¾Æ³ª ¹Ì¼÷¾ÆÀÇ ½Å»ý¾Æ ÀÇ·á¿¡¼­µµ »ê¼Ò ¿ä¹ýÀÌ ½ÃÇàµÇ°í ÀÖÀ¸¸ç, Ãë¾àÇÑ È¯ÀÚÀÇ »ýÁ¸À² Çâ»ó¿¡ µµ¿òÀ» ÁÖ°í ÀÖ½À´Ï´Ù. ¸» ÀÇ·á¿¡¼­ »ê¼Ò ¿ä¹ýÀº ¿îµ¿À¸·Î ÀÎÇÑ ÆóÃâÇ÷À̳ª È£Èí±â °¨¿°À» ¾Î°í ÀÖ´Â °æÁÖ¸¶³ª Çö¿ª ¸»ÀÇ Ä¡·á¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¹Ý·Áµ¿¹° º¸È£ÀÚµéÀÌ ´õ ³ôÀº ¼öÁØÀÇ µ¿¹° ÀÇ·á ¼­ºñ½º¸¦ ¿ä±¸ÇÏ´Â °¡¿îµ¥, »ê¼Ò ¿ä¹ýÀº ÇöÀç µ¿¹°º´¿ø, Àü¹® Ŭ¸®´Ð, À̵¿ Áø·á¼Ò¿¡ ³Î¸® º¸±ÞµÇ¾î Çö´ë µ¿¹° ÀÇ·á¿¡ ¾ø¾î¼­´Â ¾È µÉ Åø·Î ÀÚ¸® Àâ¾Ò½À´Ï´Ù.

µ¿¹°¿ë »ê¼Ò Ä¡·áÀÇ È¿À²¼ºÀ» ³ôÀÌ´Â ±â¼ú Çõ½ÅÀº ¾î¶² °ÍÀÌ Àִ°¡?

±â¼úÀÇ ¹ßÀüÀº µ¿¹°¿ë »ê¼Ò Ä¡·áÀÇ È¿°ú, ¾ÈÀü¼º, Á¢±Ù¼ºÀ» Å©°Ô Çâ»ó½ÃŰ°í ´Ù¾çÇÑ Ä¡·á ¿ä±¸¿¡ ´ëÇÑ ÀûÀÀ¼ºÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù. °¡Àå ÁÖ¸ñÇÒ ¸¸ÇÑ ±â¼ú Çõ½Å Áß Çϳª´Â °íÀ¯·® »ê¼Ò Ä¡·á ½Ã½ºÅÛÀÇ °³¹ßÀÔ´Ï´Ù. ÀÌ ½Ã½ºÅÛÀº ȯÀÚ °³°³ÀÎÀÇ Çʿ信 µû¶ó »ê¼Ò ³óµµ¸¦ Á¤È®ÇÏ°Ô Á¶ÀýÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ½Ã½ºÅÛÀº È£Èí°ï¶õÀÌ ½ÉÇÑ µ¿¹°¿¡°Ô ´õ ³ªÀº ȯ±â Áö¿øÀ» Á¦°øÇϰí, Àå½Ã°£ »ê¼Ò ³ëÃâ¿¡ µû¸¥ ÇÕº´Áõ À§ÇèÀ» ÁÙ¿©ÁÝ´Ï´Ù. ÈÞ´ë¿ë »ê¼Ò¹ß»ý±âÀÇ µµÀÔÀº µ¿¹°¿ë »ê¼Ò ¿ä¹ýÀÇ Çõ½ÅÀ» °¡Á®¿ÔÀ¸¸ç, ¼öÀǻ簡 ±âÁ¸ º´¿ø ȯ°æ ¿ÜÀÇ Àå¼Ò, ƯÈ÷ ¿Ü·¡ ¹× ÇöÀå ¼öÀÇÇп¡¼­ Áö¼ÓÀûÀÎ »ê¼Ò Åõ¿©¸¦ ÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀÚµ¿ ¿Âµµ ¹× ½Àµµ Á¶Àý ±â´ÉÀ» °®Ãá »ê¼Ò ÄÉÀÌÁö¿Í Èĵ嵵 Àα⸦ ²ø°í ÀÖÀ¸¸ç, ÁßÁõ ȯÀÚ¿¡°Ô ½ºÆ®·¹½º ¾ø´Â ÅëÁ¦µÈ ȯ°æÀ» Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ °í¾Ð»ê¼ÒÄ¡·á(HBOT)ÀÇ ¹ßÀüÀ¸·Î µ¿¹°¿ë »ê¼ÒÄ¡·áÀÇ ¹üÀ§°¡ È®´ëµÇ¾î ½É°¢ÇÑ »óó, È­»ó, ¼ö¼ú ÈÄ È¸º¹ µîÀÇ »óÅ¿¡ ´ëÇÑ Ä¡À¯ ´É·ÂÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ÆÞ½º¿Á½Ã¹ÌÅÍ ¹× Ä«ÇÁ³ë±×·¡ÇÇ ½Ã½ºÅÛÀ» Æ÷ÇÔÇÑ ½Ç½Ã°£ ¸ð´ÏÅ͸µ ÀåºñÀÇ ÅëÇÕÀº »ê¼Ò Æ÷È­µµ ¹× È£Èí ±â´ÉÀ» Á¤È®ÇÏ°Ô ÃßÀûÇÏ¿© ȯÀÚÀÇ ¾ÈÀüÀ» Çâ»ó½Ã۰í Ä¡·á Áß ÃÖÀûÀÇ »ê¼Ò °ø±ÞÀ» º¸ÀåÇÕ´Ï´Ù.

µ¿¹°¿ë »ê¼ÒÄ¡·á ½ÃÀåÀÌ Á÷¸éÇÑ °úÁ¦´Â?

ÀÌ·¯ÇÑ ÀåÁ¡¿¡µµ ºÒ±¸ÇÏ°í µ¿¹°¿ë »ê¼Ò ¿ä¹ýÀÇ º¸±ÞÀº Á¢±Ù¼º°ú ¼ö¿ë¼ºÀ» Á¦ÇÑÇÏ´Â ¸î °¡Áö °úÁ¦¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ÁÖ¿ä ¿ì·Á »çÇ× Áß Çϳª´Â °í±Þ »ê¼Ò °ø±Þ ½Ã½ºÅÛ, °í¾Ð »ê¼Ò½Ç, ¿¬¼Ó ¸ð´ÏÅ͸µ ÀåÄ¡¿Í °ü·ÃµÈ ³ôÀº ºñ¿ëÀ¸·Î, ¼Ò±Ô¸ð µ¿¹°º´¿øÀÌ ÀÌ·¯ÇÑ ±â¼ú¿¡ ÅõÀÚÇÏ´Â °ÍÀ» ¾î·Æ°Ô ¸¸µé°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ »ê¼Ò¿ä¹ýÀº »ê¼Ò Áßµ¶ µîÀÇ ÇÕº´ÁõÀ» ¿¹¹æÇϱâ À§ÇØ Àü¹®ÀûÀÎ ÈÆ·Ã°ú ¸ð´ÏÅ͸µÀÌ ÇÊ¿äÇϸç, ¼öÀÇÇÐ Àü¹®°¡¿¡ ÀÇÇÑ Áö¼ÓÀûÀÎ ±³À°°ú ±â¼ú °³¹ßÀÌ ÇÊ¿äÇÕ´Ï´Ù. ÀÇ·á¿ë »ê¼Ò¸¦ º¸°ü ¹× ¿î¼ÛÇÒ ¶§ ¹ß»ýÇÏ´Â ¹°·ù ¹®Á¦´Â ƯÈ÷ Áö¹æÀ̳ª À̵¿ÀÌ ¸¹Àº µ¿¹°º´¿ø¿¡¼­ »ê¼ÒÀÇ »ç¿ëÀ» ´õ¿í º¹ÀâÇÏ°Ô ¸¸µé°í ÀÖ½À´Ï´Ù. ¸»À̳ª °¡ÃàÀÇ °æ¿ì, µ¿¹°ÀÇ Å©±â¿Í À̵¿¼º ¶§¹®¿¡ »ê¼Ò ¿ä¹ýÀ» Á¦°øÇÏ´Â °ÍÀÌ ¾î·Á¿ï ¼ö ÀÖÀ¸¸ç, Ưº°È÷ ¼³°èµÈ Àåºñ°¡ ÇÊ¿äÇϹǷΠºñ¿ë ºÎ´ãÀÌ Ä¿Áý´Ï´Ù. ¶ÇÇÑ »ê¼Ò ½Ç¸°´õ¿Í ³óÃà±âÀÇ º¸°ü ¹× Ãë±Þ¿¡ ´ëÇÑ ±ÔÁ¦ ¿ä°ÇÀÌ Áö¿ª¸¶´Ù ´Ù¸£±â ¶§¹®¿¡ µ¿¹°º´¿ø¿¡ ÄÄÇöóÀ̾𽺠¹®Á¦°¡ ¹ß»ýÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹®Á¦¸¦ ÇØ°áÇϱâ À§Çؼ­´Â ºñ¿ë È¿À²ÀûÀÎ ¼Ö·ç¼ÇÀ» °³¹ßÇϰí, ¼öÀÇ»ç ±³À°À» °³¼±Çϸç, µµ½Ã¿Í ¿Üµý Áö¿ª ¸ðµÎ¿¡¼­ »ê¼Ò Ä¡·á ±â¼ú¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» ³ôÀ̱â À§ÇÑ ¾÷°è Àü¹ÝÀÇ ³ë·ÂÀÌ ÇÊ¿äÇÕ´Ï´Ù.

µ¿¹°¿ë »ê¼ÒÄ¡·á ½ÃÀåÀÇ ÁÖ¿ä ¼ºÀå ÃËÁø¿äÀÎÀº ¹«¾ùÀΰ¡?

µ¿¹°¿ë »ê¼Ò ¿ä¹ý ½ÃÀåÀÇ ¼ºÀåÀº ¹Ý·Áµ¿¹°ÀÇ È£Èí±â Áúȯ À¯º´·ü Áõ°¡, ¹Ý·Áµ¿¹° ¾çÀ°·ü Áõ°¡, ¼öÀÇÇÐÀû ÁßȯÀÚ Ä¡·áÀÇ ¹ßÀü µî ¿©·¯ °¡Áö ¿äÀο¡ ÀÇÇØ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. ƯÈ÷ ´ÜµÎÁ¾ ¹Ý·Áµ¿¹° º¸È£ÀÚµé »çÀÌ¿¡¼­ ¹Ý·Áµ¿¹°ÀÇ È£Èí±â °Ç°­ ¹®Á¦¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ »ê¼Ò Ä¡·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ´õ ¸¹Àº ½Ã¼³µéÀÌ Ã·´Ü »ý¸í À¯Áö ±â¼ú¿¡ ÅõÀÚÇϰí ÀÖÀ¸¸ç, µ¿¹° Àü¹® Ŭ¸®´Ð°ú ÀÀ±ÞÀÇ·á¼¾ÅÍÀÇ È®ÀåÀº »ê¼Ò ¿ä¹ý äÅÿ¡ ´õ¿í ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¹Ý·Áµ¿¹°ÀÇ ¿Ü»ó, ¼ö¼ú, ¸¸¼º ½ÉÀåÁúȯÀÇ ¹ß»ý·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¼ö¼ú ÈÄ ¹× ÁßȯÀڽǿ¡¼­ÀÇ »ê¼Ò °ø±ÞÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÈÞ´ë°¡ °¡´ÉÇÏ°í ºñ¿ë È¿À²ÀûÀÎ »ê¼Ò Ä¡·á ÀåºñÀÇ °³¹ß·Î Ä¡·á°¡ ´õ¿í Ä£¼÷ÇØÁ® ¸¸¼ºÁúȯ °ü¸®¸¦ À§ÇÑ ÀçÅà °£È£ ÇöÀå¿¡¼­ ³Î¸® äÅõǰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Àç»ýÀÇ·á ¹× ¼ö¼ú ÈÄ È¸º¹À» À§ÇÑ °í¾Ð»ê¼Ò¿ä¹ýÀÇ È°¿ëÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ¼öÀÇ»çµéÀÌ Ä¡À¯ ÃËÁø ¹× ¿°Áõ ¾ïÁ¦¿¡ ´ëÇÑ ÀÌÁ¡À» ¸ð»öÇϰí ÀÖ´Â °Íµµ ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ µ¿¹°º´¿øÀÇ ½º¸¶Æ® ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ÅëÇÕÀÌ ÁøÇàµÊ¿¡ µû¶ó »ê¼Ò ¿ä¹ý Åõ¿©ÀÇ È¿À²¼ºÀÌ Çâ»óµÇ°í, »ê¼Ò ¼öÁØÀÇ Á¤È®ÇÑ Á¦¾î°¡ º¸ÀåµÇ¾î ȯÀÚÀÇ ¾ÈÀüÀÌ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. Áö¼ÓÀûÀÎ ±â¼ú ¹ßÀü°ú µ¿¹° ÀÇ·á¿¡¼­ »ê¼Ò ¿ä¹ýÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ½ÃÀåÀº ÇâÈÄ ¼ö³â°£ Áö¼ÓÀûÀ¸·Î È®´ëµÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ºÎ¹®

Á¦Ç°(µ¿¹°¿ë »ê¼Ò¹ß»ý±â, ¾×¼¼¼­¸®), ¿ëµµ(ICU, ÀçÅà ÀÇ·á/¼ö¼úÈÄ Äɾî, ±âŸ), ÃÖÁ¾ ¿ëµµ(µ¿¹°º´¿ø, µ¿¹° Áø·á¼Ò, ±âŸ)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI Åø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM³ª ¾÷°èº° SLM Äõ¸®¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ´ë·® ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÔ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Veterinary Oxygen Therapy Market to Reach US$1.6 Billion by 2030

The global market for Veterinary Oxygen Therapy estimated at US$1.2 Billion in the year 2024, is expected to reach US$1.6 Billion by 2030, growing at a CAGR of 5.7% over the analysis period 2024-2030. Veterinary Oxygen Concentrators, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$971.6 Million by the end of the analysis period. Growth in the Accessories segment is estimated at 7.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$321.1 Million While China is Forecast to Grow at 8.7% CAGR

The Veterinary Oxygen Therapy market in the U.S. is estimated at US$321.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$327.4 Million by the year 2030 trailing a CAGR of 8.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.8% and 5.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Global Veterinary Oxygen Therapy Market - Key Trends & Drivers Summarized

Why Is Veterinary Oxygen Therapy Gaining Importance in Animal Healthcare?

Veterinary oxygen therapy has become an essential component of critical care and emergency medicine, providing life-saving respiratory support for animals suffering from hypoxia, respiratory distress, and post-surgical complications. As veterinary medicine advances, the need for supplemental oxygen has expanded beyond traditional intensive care units to include preoperative and postoperative recovery, trauma care, and the management of chronic respiratory conditions such as pneumonia, tracheal collapse, and congestive heart failure in pets. Small animals, particularly brachycephalic breeds like bulldogs and pugs, are especially prone to respiratory distress, necessitating oxygen therapy in both acute and chronic treatment settings. Additionally, oxygen therapy is increasingly used in neonatal care for underdeveloped or premature newborns, helping to improve survival rates in fragile patients. In equine medicine, oxygen therapy plays a crucial role in treating racehorses and working horses suffering from exercise-induced pulmonary hemorrhage and respiratory infections. With pet owners demanding higher standards of veterinary care, oxygen therapy is now widely integrated into veterinary hospitals, specialty clinics, and mobile veterinary units, making it an indispensable tool in modern animal healthcare.

What Innovations Are Improving the Efficiency of Veterinary Oxygen Therapy?

Technological advancements are significantly enhancing the effectiveness, safety, and accessibility of veterinary oxygen therapy, making it more adaptable to diverse treatment needs. One of the most notable innovations is the development of high-flow oxygen therapy systems, which allow for precise oxygen concentration adjustments to meet the specific needs of individual patients. These systems provide better ventilation support for animals with severe respiratory distress, reducing the risk of complications associated with prolonged oxygen exposure. The introduction of portable oxygen concentrators has further revolutionized veterinary oxygen therapy, allowing veterinarians to administer continuous oxygen support outside of traditional hospital settings, particularly in ambulatory and field veterinary care. Oxygen cages and hoods equipped with automated temperature and humidity control features are also gaining popularity, providing a controlled and stress-free environment for critically ill patients. Additionally, advancements in hyperbaric oxygen therapy (HBOT) are expanding the scope of veterinary oxygen treatment, offering enhanced healing capabilities for conditions such as severe wounds, burns, and post-surgical recovery. The integration of real-time monitoring devices, including pulse oximeters and capnography systems, has improved patient safety by enabling precise tracking of oxygen saturation and respiratory function, ensuring optimal oxygen delivery during treatment.

What Are the Challenges Facing the Veterinary Oxygen Therapy Market?

Despite its benefits, the widespread adoption of veterinary oxygen therapy faces several challenges that limit accessibility and affordability. One of the primary concerns is the high cost associated with advanced oxygen delivery systems, hyperbaric oxygen chambers, and continuous monitoring devices, making it difficult for smaller veterinary clinics to invest in these technologies. Additionally, oxygen therapy requires specialized training and monitoring to prevent complications such as oxygen toxicity, necessitating continued education and skill development among veterinary professionals. The logistical challenges of storing and transporting medical-grade oxygen further complicate its availability, particularly in rural and mobile veterinary practices. In equine and livestock applications, providing oxygen therapy can be challenging due to the size and mobility of the animals, requiring specially designed equipment that adds to the cost burden. Furthermore, regulatory requirements surrounding the storage and handling of oxygen cylinders and concentrators vary across different regions, creating compliance challenges for veterinary facilities. Addressing these issues requires industry-wide efforts to develop cost-effective solutions, improve practitioner training, and enhance accessibility to oxygen therapy technologies in both urban and remote veterinary settings.

What Are the Key Growth Drivers of the Veterinary Oxygen Therapy Market?

The growth in the veterinary oxygen therapy market is driven by several factors, including the increasing prevalence of respiratory disorders in companion animals, rising pet ownership, and advancements in veterinary critical care. The growing awareness of respiratory health issues in pets, particularly among owners of brachycephalic breeds, has significantly boosted demand for oxygen therapy solutions. The expansion of veterinary specialty clinics and emergency care centers has further fueled the adoption of oxygen therapy, as more facilities invest in advanced life-support technologies. Additionally, the rising incidence of trauma cases, surgical interventions, and chronic heart conditions in pets has led to a greater need for oxygen supplementation in postoperative and intensive care units. The development of portable and cost-effective oxygen therapy devices has made the treatment more accessible, enabling wider adoption in home care settings for chronic disease management. The increasing use of hyperbaric oxygen therapy in regenerative medicine and post-operative recovery is also driving market growth, as veterinarians explore its benefits in accelerating healing and reducing inflammation. Furthermore, the growing integration of smart monitoring systems in veterinary practices is improving the efficiency of oxygen therapy administration, ensuring precise control of oxygen levels and enhancing patient safety. With continuous technological advancements and increasing awareness of the benefits of oxygen therapy in veterinary medicine, the market is expected to witness sustained expansion in the coming years.

SCOPE OF STUDY:

The report analyzes the Veterinary Oxygen Therapy market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Veterinary Oxygen Concentrators, Accessories); Application (ICU, Homecare setting / postoperative care, Others); End-Use (Veterinary Hospitals, Veterinary Clinics, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â